10 September 2025 | Sands Expo & Convention Centre, Singapore
Asia Pacific Biologics CDMO Excellence Award 2025 aims to celebrate the outstanding contributions of leading Contract Development and Manufacturing Organisations (CDMOs) that are accelerating biologics innovation across Asia Pacific. This prestigious award recognises excellence in biomanufacturing, cutting-edge R&D, technological innovation, and strategic partnerships that drive the development and commercialisation of novel biologic therapies.
Honouring pioneers, visionaries and trailblazers in the biologics outsourcing space—from early-stage process development to large-scale commercial manufacturing—the APAC Biologics CDMO Excellence Award applauds those setting new industry benchmarks and raising the standard of biomanufacturing in the region.
The Awards Ceremony will take place in conjunction with the 4th Annual Biologics CDMO Asia 2025, on 10th September 2025, in Singapore.
Timeline of Asia Pacific Biologics CDMO Excellence Award 2025
Why our awards?
The Asia Pacific Biologics CDMO Excellence Award 2025 celebrates the outstanding contributions of leading Contract Development and Manufacturing Organisations (CDMOs) accelerating biologics innovation across the region. This prestigious award recognises excellence in biomanufacturing, cutting-edge R&D, technological breakthroughs, and strategic partnerships that shape the future of biologic therapies.
Honouring pioneers, visionaries and trailblazers in the biologics outsourcing landscape, the award applauds those setting new industry benchmarks — from early-stage process development to large-scale commercial manufacturing.
The Awards Ceremony will take place at the 4th Annual Biologics CDMO Asia 2025, on 10th September 2025, in Singapore.
